ArticleScientific reports2025
Preferred surgical strategies for bladder diverticular carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
To investigate the safety and efficacy of laparoscopic partial cystectomy in the treatment of bladder diverticular carcinoma. A retrospective analysis was performed on the clinical data of 12 patients diagnosed with bladder diverticular carcinoma who were treated at Quanzhou First Hospital Affiliated to Fujian Medical University between January 2016 and May 2023. All patients underwent laparoscopic partial cystectomy. The study assessed surgical parameters (e.g., operation time, intraoperative blood loss), pathological findings (tumor grade, stage, surgical margin status), postoperative complications, adjuvant treatment regimens, and long-term follow-up outcomes (tumor recurrence, survival status). All 12 operations were completed successfully without major intraoperative complications. Postoperative pathology confirmed bladder urothelial carcinoma in all cases, with negative surgical margins in all patients. Postoperatively, all patients received regular intravesical instillation chemotherapy. Additionally, 5 patients underwent systemic intravenous chemotherapy, and 1 patient received intra-arterial chemotherapy as adjuvant treatment to reduce the risk of tumor recurrence. The median follow-up duration was 16-49 months. During follow-up, 11 patients remained free of tumor recurrence, while 1 patient developed recurrent bladder cancer at 15 months postoperatively (subsequently managed with transurethral resection of bladder tumor and adjuvant radiotherapy, achieving long-term survival). Laparoscopic partial cystectomy is a safe and effective therapeutic option for bladder diverticular carcinoma, characterized by low postoperative complication rates and favorable tumor control. Larger-sample, multi-center studies with longer follow-up are needed to further validate its long-term prognostic benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.